1102867

Elizabeth Plimack, MD, MS — FEI 3015360837

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance